Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
Madrigal’s Rezdiffra storms past blockbuster milestone
Madrigal plans to launch a 2,000-subject study focused on MASH patients with clinically significant portal hypertension.
Angus Liu
Nov 3, 2026 3:23pm
Amgen names internal successor as quality chief retires
Nov 3, 2026 3:21pm
DTP – Delivering Proof Over Promise
Brought to you by
Gifthealth
Pfizer tops Q3 estimates with strong sales and cost cuts
Nov 3, 2026 11:51am
How AI turns field conversations into actionable insights
Brought to you by
Inizio Ignite
Pharma rebound puts Bayer split debate back on the table
Nov 3, 2026 11:27am